HUP0302664A2 - Vakcináció gazdasejttel asszociált herpeszvírusok ellen - Google Patents

Vakcináció gazdasejttel asszociált herpeszvírusok ellen

Info

Publication number
HUP0302664A2
HUP0302664A2 HU0302664A HUP0302664A HUP0302664A2 HU P0302664 A2 HUP0302664 A2 HU P0302664A2 HU 0302664 A HU0302664 A HU 0302664A HU P0302664 A HUP0302664 A HU P0302664A HU P0302664 A2 HUP0302664 A2 HU P0302664A2
Authority
HU
Hungary
Prior art keywords
vaccination against
host cell
against host
herpesviruses
marek
Prior art date
Application number
HU0302664A
Other languages
English (en)
Inventor
Frank Fehler
Klaus Osterrieder
Original Assignee
Lohmann Animal Health Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health Gmbh & Co. Kg filed Critical Lohmann Animal Health Gmbh & Co. Kg
Publication of HUP0302664A2 publication Critical patent/HUP0302664A2/hu
Publication of HUP0302664A3 publication Critical patent/HUP0302664A3/hu
Publication of HU228262B1 publication Critical patent/HU228262B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya úgynevezett gazdasejttel asszociált herpeszvírusok,például baromfik Marek-féle betegségének vírusa (MDV) és emberekbenelőforduló Varicella Zoster vírus (VZV, amely csirkehimlőt és zostertokoz látenciából való reaktiválódás után) elleni vakcináció és azilyen vírusok által okozott betegségek elleni vakcinációszakterületére tartozik, közelebbről baromfibetegségek, különösen aMarek-féle betegség elleni vakcináció területére. Ó
HU0302664A 2000-08-03 2001-08-01 Vaccination against host cell-associated herpesviruses HU228262B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202757A EP1178111A1 (en) 2000-08-03 2000-08-03 Vaccination against host cell-associated herpesviruses
PCT/EP2001/008893 WO2002012288A2 (en) 2000-08-03 2001-08-01 Vaccination against host cell-associated herpesviruses

Publications (3)

Publication Number Publication Date
HUP0302664A2 true HUP0302664A2 (hu) 2003-11-28
HUP0302664A3 HUP0302664A3 (en) 2004-10-28
HU228262B1 HU228262B1 (en) 2013-02-28

Family

ID=8171884

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302664A HU228262B1 (en) 2000-08-03 2001-08-01 Vaccination against host cell-associated herpesviruses

Country Status (24)

Country Link
US (1) US9073979B2 (hu)
EP (2) EP1178111A1 (hu)
JP (1) JP4313036B2 (hu)
KR (1) KR100633180B1 (hu)
CN (2) CN102151333A (hu)
AT (1) ATE412055T1 (hu)
AU (2) AU2001291716B2 (hu)
BR (1) BRPI0112989B1 (hu)
CA (1) CA2417923C (hu)
CZ (1) CZ303904B6 (hu)
DE (1) DE60136278D1 (hu)
EA (1) EA010721B1 (hu)
ES (1) ES2315306T3 (hu)
HR (1) HRP20030147B1 (hu)
HU (1) HU228262B1 (hu)
IL (2) IL154250A0 (hu)
MX (1) MXPA03001027A (hu)
NO (1) NO332621B1 (hu)
NZ (1) NZ524066A (hu)
PL (1) PL207958B1 (hu)
PT (1) PT1307565E (hu)
UA (1) UA84667C2 (hu)
WO (1) WO2002012288A2 (hu)
ZA (1) ZA200300842B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1178111A1 (en) 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses
CA2558586A1 (en) * 2004-03-05 2005-09-15 The Research Foundation For Microbial Diseases Of Osaka University Recombinant varicella-zoster virus
US9273326B2 (en) 2004-04-30 2016-03-01 The Brigham And Women's Hospital, Inc. Tetracycline-regulated gene expression in HSV-1 vectors
US20080226677A1 (en) * 2004-05-06 2008-09-18 Yasuko Mori Recombinant virus vector for gene transfer into lymphoid cells
ES2732815T3 (es) 2009-05-22 2019-11-26 Genocea Biosciences Inc Vacunas frente al virus del herpes simple de tipo 2: composiciones y métodos para provocar una respuesta inmunitaria
SI2516629T1 (sl) 2009-12-21 2016-10-28 The Brigham And Women's Hospital, Inc. Cepiva proti virusu herpes simplex
CA2856697A1 (en) * 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA3206983A1 (en) * 2011-10-21 2013-04-25 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
JP6199878B2 (ja) * 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
CN105561303B (zh) * 2015-12-30 2019-04-05 暨南大学 单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法
CN105597095A (zh) * 2015-12-30 2016-05-25 暨南大学 一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法
CN105641692A (zh) * 2015-12-30 2016-06-08 暨南大学 单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
US11174322B2 (en) * 2017-07-24 2021-11-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies and peptides to treat HCMV related diseases
MX2020006343A (es) * 2017-12-20 2020-09-03 Intervet Int Bv Diluyente mejorado para vacuna de herpesvirus alfa asociado con celulas.
WO2019152821A1 (en) 2018-02-05 2019-08-08 The Brigham And Women's Hospital, Inc. Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
EP0486106A3 (en) 1990-11-16 1992-12-23 Akzo N.V. Marek's disease virus vaccine
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
JP3675569B2 (ja) 1995-04-28 2005-07-27 日本ゼオン株式会社 組み換えウイルス及びそれよりなるワクチン
KR19990028766A (ko) 1995-07-07 1999-04-15 나카노 가쓰히꼬 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도
US6306387B1 (en) * 1997-05-29 2001-10-23 The Research Foundation Of State University Of New York Antigen delivery system
DE19733364A1 (de) * 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Verfahren zur Klonierung eines großen Virusgenoms
AUPP684998A0 (en) * 1998-10-30 1998-11-26 Murdoch Institute for Research into Birth Defects Limited, The A method of recombination and agents useful for same
EP1038952A3 (en) 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6299882B1 (en) 1999-04-09 2001-10-09 Schering Corporation UL54.5 of Marek's disease virus (MDV)
EP1178111A1 (en) 2000-08-03 2002-02-06 Lohmann Animal Health GmbH & Co. KG Vaccination against host cell-associated herpesviruses

Also Published As

Publication number Publication date
BRPI0112989B1 (pt) 2015-09-08
ATE412055T1 (de) 2008-11-15
PL207958B1 (pl) 2011-02-28
NO20030524L (no) 2003-04-03
NO20030524D0 (no) 2003-02-03
CA2417923A1 (en) 2002-02-14
IL154250A0 (en) 2003-09-17
JP4313036B2 (ja) 2009-08-12
DE60136278D1 (de) 2008-12-04
CN1503843A (zh) 2004-06-09
CZ2003324A3 (cs) 2003-06-18
IL154250A (en) 2013-07-31
AU9171601A (en) 2002-02-18
US9073979B2 (en) 2015-07-07
US20030165537A1 (en) 2003-09-04
KR100633180B1 (ko) 2006-10-11
ZA200300842B (en) 2004-04-30
HRP20030147A2 (en) 2005-04-30
CA2417923C (en) 2010-06-29
PL365190A1 (en) 2004-12-27
CN102151333A (zh) 2011-08-17
KR20030036657A (ko) 2003-05-09
MXPA03001027A (es) 2004-02-26
JP2004505993A (ja) 2004-02-26
UA84667C2 (ru) 2008-11-25
EP1307565A2 (en) 2003-05-07
PT1307565E (pt) 2009-01-28
NZ524066A (en) 2004-11-26
EA010721B1 (ru) 2008-10-30
ES2315306T3 (es) 2009-04-01
CZ303904B6 (cs) 2013-06-19
AU2001291716B8 (en) 2002-02-18
EP1307565B1 (en) 2008-10-22
WO2002012288A3 (en) 2002-04-11
HRP20030147B1 (en) 2011-10-31
AU2001291716B2 (en) 2007-06-07
BR0112989A (pt) 2003-09-09
HU228262B1 (en) 2013-02-28
WO2002012288A2 (en) 2002-02-14
NO332621B1 (no) 2012-11-19
HUP0302664A3 (en) 2004-10-28
EP1178111A1 (en) 2002-02-06
EA200300215A1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
HUP0302664A2 (hu) Vakcináció gazdasejttel asszociált herpeszvírusok ellen
Arvin et al. Human herpesviruses: biology, therapy, and immunoprophylaxis
Mettenleiter Molecular biology of pseudorabies (Aujeszky's disease) virus
ES2261243T3 (es) Composiciones de vacuna combinada.
García et al. Genomic sequence analysis of the United States infectious laryngotracheitis vaccine strains chicken embryo origin (CEO) and tissue culture origin (TCO)
WO2000061736A3 (en) Recombinant and mutant marek's disease virus
EA200701633A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
Field et al. Herpesvirus latency and therapy—from a veterinary perspective
HUP0102861A2 (hu) Attenuált lóherpeszvírus
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
DE68929181D1 (de) Virale nucleotidsequenzen
Wyrwicz et al. Herpes glycoprotein gL is distantly related to chemokine receptor ligands
Stewart Of mice and men: murine gammaherpesvirus 68 as a model
Mariappan et al. Marek’s disease virus
Oh et al. Effect of smoked tobacco tar on the growth, cytolytic action, DNA synthesis, and gene expression of herpes simplex virus
HUP0202738A2 (hu) Ló herpeszvírus hőérzékeny mutánsa és az abból készített élő oltóanyag
BR0304750A (pt) Mutante de herpesvìrus bovino tipo 5, vacina dirigida contra a encefalite viral bovina (bhv-s) e o vìrus rábico e método de preparação da vacina
WO2002081712A3 (en) Artificial chromosomes comprising ehv sequences
AU2003298838A1 (en) Escape mutants of newcastle disease virus as marker vaccines
RU95104923A (ru) Штамм вируса герпеса кур "42" - деп для изготовления вакцины против болезни марека
Reddy et al. Novel insights in the pathogenesis of infectious laryngotracheitis and bronchitis viruses in chickens
Cohen Virology and Diagnosis
RU95104924A (ru) Штамм вируса герпеса кур "50" - деп для изготовления вакцины против болезни марека
Bourne et al. Pathogenesis of Drug Resistant Clinical HSV-2 Isolates in the Guinea Pig Model of Genital Herpes.
RU94042470A (ru) Поливалентная вакцина для профилактики болезни марека и способ ее изготовления

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ELANCO TIERGESUNDHEIT AG, CH

Free format text: FORMER OWNER(S): LOHMANN ANIMAL HEALTH GMBH & CO. KG, DE; LOHMANN ANIMAL HEALTH GMBH, DE